Pneumococcal conjugate second or third-dose vaccines (PCVc) in Slovenia
Slovenia: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 55.0% in 2025. ◆ Volatile
Latest (2025)
55.0%
Change on year
down 1.8%
World rank
152nd
of 194 countries
All-time high
70.0%
in 2020
All-time low
0.0%
in 2008
Years of data
18
2008–2025
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Slovenia, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, pneumococcal conjugate second or third-dose vaccines (pcvc) in Slovenia stood at 55.0%.
That represents a change of down 1.8% on the previous year and up 10.0% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Slovenia peaked at 70.0% in 2020 and was at its lowest, 0.0%, in 2008.
That places Slovenia 152nd out of 194 countries with data for 2025, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Slovenia, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 0.0% | — |
| 2014 | 0.0% | — |
| 2015 | 50.0% | — |
| 2016 | 50.0% | +0.0% |
| 2017 | 55.0% | +10.0% |
| 2018 | 60.0% | +9.1% |
| 2019 | 65.0% | +8.3% |
| 2020 | 70.0% | +7.7% |
| 2021 | 58.0% | -17.1% |
| 2022 | 61.0% | +5.2% |
| 2023 | 58.0% | -4.9% |
| 2024 | 56.0% | -3.4% |
| 2025 | 55.0% | -1.8% |
Slovenia compared with similar countries
- Slovenia's 55.0% is below the median for high income countries, which is 91.0%, 60% of the median. (63 countries reporting)
- Slovenia's 55.0% is below the median for Europe & Central Asia, which is 87.0%, 63% of the median. (51 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 28.0% | 0.0% | 65.0% | 10 |
| 2020s | 59.7% | 55.0% | 70.0% | 6 |
Countries ranked near Slovenia
- 151 Madagascar 56.0% compare
- 153 Angola 54.0% compare
- 153 Iran 54.0% compare
- 155 Azerbaijan 52.0% compare
More health data for Slovenia
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.8177 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,176 deaths per 1,000 people (2090)
- Number of infants who die before age 1 4 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.03 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.021 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.58 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Slovenia?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Slovenia was 55.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Slovenia?
- The highest recorded value was 70.0% in 2020.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Slovenia?
- The lowest recorded value was 0.0% in 2008.
- How does Slovenia rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Slovenia ranks 152nd out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Slovenia?
- Over the last ten years it is up 10.0%. The long-run trend across the full record is volatile.
- Where does this Slovenia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).